The TULIP prospective cohort with subjects at increased risk of developing type 2 diabetes (n = 258) to address the question whether suPAR concentrations predict onset of microalbumiuria and the ICEPHA cross-sectional cohort, consisting of patients with manifest type 2 diabetes (n = 266), to confirm an association of suPAR and urinary albumin excretion at later stages of the disease. Here, ALB is linked to type 2 diabetes mellitus.